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Identity 
Other names: MT2-MMP, MTMMP2, SMCP-2 



















The DNA sequence contains 10 exons and the 




MT2-MMP belongs to which consist a gene family 
over 25 different members in humans (refer to MT1-
MMP). 
Expression 
Expression of MT2-MMP has been reported in many 
cancers, such as glioblastomas, ovarian, urothelial, and 
breast. In addition, MT2-MMP is involved in 
endothelial tubulogenesis, malignant conversion of 
keratinocytes, and is an antiapoptotic factor. 
Both MT2-MMP and MT3-MMP were detected 
predominantly at the interface between the epithelium 
and substantia propia in mice intracornea infected with
Pseudomonas aeruginosa. On the other hand, MT1-
MMP was mainly expressed at epithelium in the same 
tissue (Dong et al., 2000). During pregnancy, MT2-
MMP is expressed in the invaded cytotrophoblasts 
where both MT1-MMP and gelatinase A are 
extensively colocalized (Bjørn et al., 2000). 
Over all, MT2-MMP may plays an important and 





In a previous study with a cell line established from 
MT1-MMP gene knocked-out mice, MT2-MMP has 
been suggested to contribute alternatively to cell 
invasion through fibrin rich matrices (Hotary et al., 
2002). 
Like as MT1-MMP, MT2-MMP may also play some 
role in MMP-2 activation in microenvironment with 
TIMP-2 involvement (Morrison et al., 2001; Morrison 
and Overall, 2006). 
In corporation with the enzymatic action of MT1-
MMP, MT2-MMP can contribute to remodel basement 
membrane (Hotary et al., 2000; Hotary et al., 2006). 
Development  
1) Branching morphogenesis 
MT2-MMP has been shown to be induced to the 
epithelia in migration, thereby speculated to be 
involved in branching morphogenesis of salivery gland 
(Harunaga et al., 2011), and submandibular gland 
(Rebustini et al., 2009). 
2) Cardia valve development in endocardial cushion 
Cardiac valve is constituted by tissue-specific 
fibroblasts originated from endocardial cushion through 
EMT. It has been demonstrated that MT2-MMP, which 
may play a key role in the valve formation, is likey 
expressed at the period of EMT by Snail1-related signal 
(Tao et al., 2011). 
3) Placenta development (chorionic villus) 
It has been demonstrated by separate research groups 
that MT2-MMP may play a important role in placental 
labyrinth formation at the period of embryogenesis or 
in menstrual cycle (Szabova et al., 2010; Plaisier et al., 
2006). During the placenta development, MT2-MMP is 
induced at trophoblasts under TNF alpha-related signal. 
Homology 
MT2-MMP is supposed to be 72 kDa in molecular 




Both MT1-MMP and MT2-MMP have potential to play 
important role in cancer either for proliferation or
transmigration through extracellular matrix (ECM). Ota 
and his colleagues have suggested that membrane-
localized proteolytic enzyme such as MT1/2-MMP can 
be induced and recruited towards the tumor cell surface 
during epithelial-mesenchymal transition (EMT) 
mediated by Snail1-related signal (Ota et al., 2009). 
Other group has indicated that cancer cells, such as 
PANC-1, induce MT2-MMP under hypoxia in a HIF-1 
dependent manner (Zhu et al., 2011). These data 
suggest MT2-MMP may play some role in cancer 
progression against the physiological stress. It has not 
been clarified, however, that MT2-MMP can entirely 
substitute the function of MT1-MMP and vice versa.  
Several IHS analyses with clinical samples suggested  
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that MT2-MMP is expressed in several tumor types 
which include esophageal (Chen et al., 2010), bladder 
(Mohammad et al., 2010), colorectal (Lyall et al., 
2006), and urothelial carcinoma (Kitagawa et al., 
1998). In such reports for the colorectal and bladder 
cancer, the expression of MT2-MMP was shown to be 
associated with disease prognosis (Lyall et al., 2006; 
Mohammad et al., 2010). 
Idiopathic pulmonary fibrosis (IPF) 
Note 
IPF is a disease characterized by fibroblast expansion 
and ECM accumulation in lung. A previous report 
suggests MT1-MMP as well as MT2-MMP, was 
expressed in alveolar epithelial cells, and active MMP-
2 was increased in bronchoalveolar lavage (BAL) 
fluids in IPF tissue. These MMPs possibly play roles in 
the pathogeny (García-Alvarez et al., 2006). 
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